Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML

Gary J. Schiller, Laura Finn, Mohamed M. Hegazi, Johnnie J. Orozco, Avinash Desai, Mary M Chen, Gail J. Roboz

Blood (2022) 140 (Supplement 1): 3336–3337.

https://doi.org/10.1182/blood-2022-157588

Published: 2022

Journal Articles

Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features

Sameem Abedin, Guru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Katelyn Gauger, Avinash G Desai, Mary M Chen, Alexandra M. Harrington, Ehab L. Atallah

Blood (2022) 140 (Supplement 1): 157–158.

https://doi.org/10.1182/blood-2022-157827

Published: 2022

Journal Articles

Endothelial Cell Activation Enhances Thromboinflammation in Vitt

Alexander Dupuy, Xiaoming Liu, Jessica Tieng, Bede Johnston, Arian Nasser, Paul Coleman, Yingqi Zhang, Lining Arnold Ju, Huyen Tran, Vivien M Chen, Elizabeth E. Gardiner, Freda H. Passam

Blood (2022) 140 (Supplement 1): 1656–1657.

https://doi.org/10.1182/blood-2022-168441

Published: 2022

Journal Articles

TMEM16E Regulates Endothelial Cell Procoagulant Activity and Thrombosis

Alec A Schmaier, Papa Freduah Anderson, Siyu M Chen, Emale Darzi, Kelsey Sack, Criss Hartzell, Robert Flaumenhaft, Samir Parikh, Sol Schulman

Blood (2022) 140 (Supplement 1): 1654–1655.

https://doi.org/10.1182/blood-2022-159639

Published: 2022

Journal Articles

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Huyen Tran, Lucy Deng, Nicholas Wood, Vivien M Chen

Blood (2022) 140 (Supplement 1): 5654–5655.

https://doi.org/10.1182/blood-2022-168844

Published: 2022

Journal Articles

Decade-Long Remissions of Leukemia Sustained By the Persistence of Activated CD4+ CAR T-Cells

Blood (2021) 138 (Supplement 1): 166.

https://doi.org/10.1182/blood-2021-152664

Published: 2021

Journal Articles

Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML

Gary J. Schiller, Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M Chen, Mohamed M. Hegazi

Blood (2021) 138 (Supplement 1): 3412.

https://doi.org/10.1182/blood-2021-146018

Published: 2021

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley

Blood (2020) 136 (26): 3070–3081.

https://doi.org/10.1182/blood.2020005397

Published: 2020

Includes: Supplemental data

Journal Articles

High E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Overcome with the Addition of Uproleselan

Daniel J. DeAngelo, MD PhD, Brian A Jonas, MD PhD, Jane L. Liesveld, MD, Dale L. Bixby, MD, Anjali S. Advani, MD, Paula Marlton, MBBS (Hons), FRACP, FRCPA, Michael E O'Dwyer, MD, William E. Fogler, PhD, John L. Magnani, PhD, Mary M Chen, MD PhD, Eric J. Feldman, MD, Helen M Thackray, MD, Pamela S. Becker, MD PhD

Blood (2019) 134 (Supplement_1): 2690.

https://doi.org/10.1182/blood-2019-123744

Published: 2019

Journal Articles

A Double-Blind, Placebo-Controlled, Phase 3 Registration Trial to Evaluate the Efficacy of Uproleselan (GMI-1271) with Standard Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia

Daniel J. DeAngelo, MD PhD, Harry P. Erba, MD PhD, Brian A Jonas, MD PhD, Michael E O'Dwyer, MD, Paula Marlton, MBBS (Hons), FRACP, FRCPA, Gerwin Huls, MD PhD, Jane L. Liesveld, MD, Brenda Cooper, MD, Bhavana Bhatnagar, DO, Geoffrey L. Uy, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Michael B. Armstrong, MD PhD, William E. Fogler, PhD, Mary M Chen, MD PhD, John L. Magnani, PhD, Helen M Thackray, MD, Eric J. Feldman, MD, Anjali S. Advani, MD, Pamela S. Becker, MD PhD

Blood (2019) 134 (Supplement_1): 2650.

https://doi.org/10.1182/blood-2019-123816

Published: 2019

Journal Articles

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Mikko Myllymaki, MD PhD, Robert A. Redd, MS, Corey S. Cutler, MD MPH, Wael Saber, MD MS, Zhen-Huan Hu, MPH, Tao Wang, PhD, Stephen R. Spellman, Christopher J. Gibson, MD, Maxine M Chen, Esther Orr, David P. Steensma, MD, Joseph H. Antin, MD, Immaculata De Vivo, Donna S Neuberg, ScD, Suneet Agarwal, MDPhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 796.

https://doi.org/10.1182/blood-2018-99-117031

Published: 2018

Journal Articles

Procoagulant Role Of Necrotic Platelets Demonstrated Using Novel Platelet Necrosis Marker

Minh Hua, MBBS, Leonardo Pasalic, MBBS, Robert Lindeman, MBBS, Philip Hogg, PhD, Vivien M Chen, MD, PhD

Blood (2013) 122 (21): 3512.

https://doi.org/10.1182/blood.V122.21.3512.3512

Published: 2013

Journal Articles

Cisplatin Fails To Stimulate Production Of Reactive Oxygen Species and Release Of Neutrophil Extracellular Traps By Human Neutrophils In Vitro

Leonardo Pasalic, MBBS, Campbell Heather, BSc, Shane Thomas, PhD, Vivien M Chen, MD, PhD

Blood (2013) 122 (21): 4714.

https://doi.org/10.1182/blood.V122.21.4714.4714

Published: 2013

Journal Articles

Laser-induced endothelial cell activation supports fibrin formation

Ben T. Atkinson, Reema Jasuja, Vivien M. Chen, Prathima Nandivada, Bruce Furie, Barbara C. Furie

Blood (2010) 116 (22): 4675–4683.

https://doi.org/10.1182/blood-2010-05-283986

Published: 2010

Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

Owen A O'Connor, J. Gerecitano, H. Van Deventer, B. Afanasyev, J. Hainsworth, M. Chen, K. Saikali, J. Seroogy, R. Escandon, A. Wolff, MG. Conlan

Blood (2009) 114 (22): 1673.

https://doi.org/10.1182/blood.V114.22.1673.1673

Published: 2009

Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff

Blood (2008) 112 (11): 1563.

https://doi.org/10.1182/blood.V112.11.1563.1563

Published: 2008

Journal Articles

YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation

Ian S. Hitchcock, Maximus M. Chen, Jennifer R. King, Kenneth Kaushansky

Blood (2008) 112 (6): 2222–2231.

https://doi.org/10.1182/blood-2008-01-134049

Published: 2008

Journal Articles

YRRL Motifs in the Cytoplasmic Domain of the Thrombopoietin Receptor Mpl Regulate Receptor Internalization and Degradation.

Ian S. Hitchcock, PhD, Maximus M. Chen, Jennifer R. King, Kenneth Kaushansky, M.D

Blood (2007) 110 (11): 90.

https://doi.org/10.1182/blood.V110.11.90.90

Published: 2007

Journal Articles

The Biphasic Effects of TIMP-2 on the Growth and Infiltration of SHI-1 Cells on Nude Mice.

L.J. Zhen, PhD, Zi X. Chen, MD, Jian N. Cen, PhD, Jun He, MD, Qiao Cheng Qiu, MD, Wen M. Chen, MD

Blood (2006) 108 (11): 4266.

https://doi.org/10.1182/blood.V108.11.4266.4266

Published: 2006

NARROW

Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML

Lintuzumab-Ac225 with Combination with Intensive Chemotherapy Yields High Response Rate and MRD Negativity in R/R AML with Adverse Features

Endothelial Cell Activation Enhances Thromboinflammation in Vitt

TMEM16E Regulates Endothelial Cell Procoagulant Activity and Thrombosis

The Clinicalpathological Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Following ChAdOx1 (AstraZeneca AZD1222) Vaccination and Case Outcomes in Australia

Decade-Long Remissions of Leukemia Sustained By the Persistence of Activated CD4+ CAR T-Cells

Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

High E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Overcome with the Addition of Uproleselan

A Double-Blind, Placebo-Controlled, Phase 3 Registration Trial to Evaluate the Efficacy of Uproleselan (GMI-1271) with Standard Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia

Telomere Length and Telomerase Complex Mutations Predict Fatal Treatment Toxicity after Stem Cell Transplantation in Patients with Myelodysplastic Syndrome

Procoagulant Role Of Necrotic Platelets Demonstrated Using Novel Platelet Necrosis Marker

Cisplatin Fails To Stimulate Production Of Reactive Oxygen Species and Release Of Neutrophil Extracellular Traps By Human Neutrophils In Vitro

Laser-induced endothelial cell activation supports fibrin formation

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation

YRRL Motifs in the Cytoplasmic Domain of the Thrombopoietin Receptor Mpl Regulate Receptor Internalization and Degradation.

The Biphasic Effects of TIMP-2 on the Growth and Infiltration of SHI-1 Cells on Nude Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only